...
Meeting date | Uploaded by | Slides | Comments |
|---|---|---|---|
2 May 2012 | Julie | PFIM Interface 3.1 - cours M2R 10-11.pdf |
|
15 May 2012 | Angelina |
| |
6 June 2012 | Joe |
| |
13 June 2012 | Joanna | EMA geriatric workshop - March 2012 - Shepard (submitted 19March).ppt | Terry Shepard's Slides |
12 October 2012 | Rollo |
| |
9 November 2012 | Joanna |
| |
13 November 2012 | Julie |
| |
14 December 2012 | Lilia | Modelling neutrophil dynamics in children following bone marrow transplant |
|
22 Februrary 2013 | Allienor Berges |
| |
1 March 2013 | Rollo |
|
List of past meetings:
Date | Location* | Presenter | Topic |
|---|---|---|---|
9 May 2012 | PUW1 | Joanna | Immunology |
16 May 2012 | WCJ | Angelina | Zidovudine PK/PG |
23 May 2012 | PUW2 | Jig | LMWH in pregnancy |
30 May 2012 | No meeting |
|
|
6 June 2012 | PUW1 | Joe | Antimicrobial PKPD |
13 June 2012 | PUW1 | Terry Shepard | Geriatric PKPD |
20 June 2012 | PUW2 | Rollo/Joanna | Immunology modelling |
27 June 2012 | No meeting |
|
|
4th July 2012 | No meeting |
|
|
11th July 2012 | PUW2 | Julie | PAGE review |
18th July 2012 | PUW2 | Katie | Gentamicin in burns |
12/10/12 1pm | WCA | Rollo | Modelling of the immune reconstitution post BMT |
19/10/12 1pm | PUW3 | Joe | Prague Biometrics 2012;68:902-11 |
26/10/12 1pm | PUW3 | Charlotte | NAPPA (Beta lactam pharmacokinetics/pharmacodynamics) plans |
2/11/12 1pm | PUW3 | Eva | Neogent (developing Bayesian therapeutic drug monitoring) progress |
9/11/12 1pm | PUW3 | Joanna | Inference methods course review |
16/11/12 1pm | PUW2 |
| General discussion |
23/11/12 1pm | PUW3 | Julie | Covariate selection methods in pharmacokinetic modelling |
30/11/12 1pm | PUW3 | Julie | NCA versus modelling in phase I studies for drugs with long half-life |
7/12/12 1pm | PUW3 |
| Goldacre talk |
14/12/12 1pm | PUW3 | Lilia | Neutropenia post-BMT |
| 4/1/13 1pm | PUW3 |
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
| General discussion | |
11/1/13 1pm | Levinsky | Joe | Maraviroc PK | |
18/1/13 1pm | PUW4 | Andrezj | PKPD bridging of response between adults and children | |
25/1/13 1pm | PUW3 | Lilia | Neutropenia following paediatric BMT | |
1/2/13 1pm | PUW1 | Mirjam Trame | Use of PKPD modeling to guide HIV understanding and treatment | |
8/2/13 1pm | PUW3 | Sami | Bioequivalence studies and genetic variability | |
15/2/13 1pm | PUW1 | Liana | ErbB inhibition for PKD | |
22/2/13 1pm | PUW3 | Alienor Berges (GSK) |
| |
1/3/13 1pm | PUW4 | Rollo | CD4 reconstitution post BMT | |
8/3/13 1pm | PUW3 | Eva | Neogent update | |
15/3/13 1pm | PUW4 | Tafi | Dose individualisation in HIV/AIDS and TB patients on Efavirenz (EFV). | |
22/3/13 1pm | PUW3 | Hui Ma | Genetic components to glucose-insulin response |